The abstract is read at the publisher; the summary is JClub's.
Endothelial PDE2A is upregulated 2 days after experimental acute myocardial infarction in mice and its inhibition reduces post-infarct myocardial and pulmonary inflammation.
- Why it matters: After AMI, endothelial barrier dysfunction enables immune cell infiltration, but the molecular pathway driving this process is not fully defined for endothelial PDE2A.
- What they did: Mice showed increased cardiac and pulmonary endothelial PDE2A alongside adhesion proteins and immune extravasation; TNF-α and interleukin-1β increased PDE2A via p38, while BAY 60-7550 boosted endothelial cAMP/cGMP and reduced thrombin- and cytokine-induced leakiness and VCAM-1/ICAM-1.
- The result: EC-restricted PDE2A deletion increased endothelial cAMP and cGMP, lowered cytokine-stimulated VCAM-1, and diminished myocardial and pulmonary inflammation after AMI, with reduced cardiac scarring and dysfunction.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.